GlaxoSmithKline is upping its presence in India again, this week saying it'll spend INR500 million ($73 million) on a plant upgrade in Nashik to expand…

Regulators in Spain are punishing a Barcelona-based drugmaker for a series of manufacturing shortfalls, recalling all batches produced by the company, Farma…

Catalent's plant in Beinheim, France, offline for four months because of suspected sabotage to products, is expected to be fully up and running next…

Some drugmakers are expanding production in Africa to take advantage of a growing number of countries where rising incomes and national healthcare can pay for…

Teva Pharmaceuticals' efforts to cut costs by making its manufacturing more efficient have landed at a plant in the U.K. where the generics leader will…

Oxford BioMedica says the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) has given approval to its new biomanufacturing facility in…

Biologics manufacturing has been expanding as drugmakers develop more and more cell-based drugs with special capabilities. Boehringer Ingelheim is jumping on…

Drug development specialist Aptuit says it plans to invest $16 million in upgrades and new equipment for its facilities in the U.K. and Italy as well as add 90…